CLBX — Cellbxhealth Balance Sheet
0.000.00%
Last trade - 00:00- £17.38m
- £15.77m
- £2.86m
Annual balance sheet for Cellbxhealth, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 31.8 | 31.9 | 16.2 | 10.4 | 7.35 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.17 | 3.71 | 2.57 | 3.38 | 1.34 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 39.4 | 38.6 | 21.2 | 16.4 | 10.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.38 | 8.48 | 7.23 | 6.4 | 1.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 47.3 | 49.9 | 31.2 | 25.5 | 12.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.91 | 5.25 | 3.94 | 3.26 | 3.77 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.99 | 9.8 | 8.24 | 7.02 | 5.39 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 40.3 | 40.1 | 22.9 | 18.4 | 7.2 |
| Total Liabilities & Shareholders' Equity | 47.3 | 49.9 | 31.2 | 25.5 | 12.6 |
| Total Common Shares Outstanding |